What is the current Price Target for the Sionna Therapeutics stock?

The average Sionna Therapeutics target price is $5.61. This is 14.26% higher than the current stock price. The highest price target is 1,247.25%, the lowest is 2.85%. 8 Analysts have issued a price target Sionna Therapeutics 2027 .

How high will the Sionna Therapeutics stock rise?

No reliable answer can be given as to how high the Sionna Therapeutics stock will rise. The performance of stocks, including the Sionna Therapeutics stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Sionna Therapeutics stock today?

The performance of Sionna Therapeutics stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Sionna Therapeutics stock fall?

The decline in Sionna Therapeutics stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Sionna Therapeutics Forecast, price target & analysts

$4.88

0.61%

Nasdaq, Oct 05, 09:48 am EDT. Market open.

ISIN

US8294011080

Symbol

SION

Reports

Quarter | Annual

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Sionna Therapeutics Target price 2026 - Analyst rating & recommendation

Sionna Therapeutics Classifications & Recommendation

Buy

35%

Hold

65%

Sionna Therapeutics Price Target

Target Price	$5.61
Price	$4.91
Potential	14.26% register free of charge
Number of Estimates	8

	8 Analysts have issued a price target Sionna Therapeutics 2027 . The average Sionna Therapeutics target price is $5.61. This is 14.26% register free of charge higher than the current stock price. The highest price target is $66.15 1,247.25% register free of charge , the lowest is $5.05 2.85% register free of charge .
	A rating was issued by 17 analysts: 6 Analysts recommend Sionna Therapeutics to buy, 11 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Sionna Therapeutics stock has an average upside potential 2027 of 14.26% register free of charge . Most analysts recommend the Sionna Therapeutics stock at Hold.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-1.88	-2.46
	29.66%	30.85%
P/E		negative

13 Analysts have issued a Sionna Therapeutics forecast for earnings per share. The average Sionna Therapeutics EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-1.88	29.66%
2026	$-2.46 30.85% unlock
2027	$-2.15 12.60% unlock
2028	$-2.56 19.07% unlock
2029	$-3.29 28.52% unlock
2030	$-2.99 9.12% unlock
2031	$-1.32 55.85% unlock
2032	$1.78 234.85% unlock
2033	$5.87 229.78% unlock

Current	-2.26	82.96%
2026	-1.99 12.05% unlock
2027	-2.28 14.57% unlock
2028	-1.92 15.79% unlock
2029	-1.49 22.40% unlock
2030	-1.64 10.07% unlock
2031	-3.72 126.83% unlock
2032	2.76 174.19% unlock
2033	0.84 69.57% unlock

Sionna Therapeutics...

Current Sionna Therapeutics Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Wedbush	Locked ➜ Locked	Locked	Sep 15 2026
Wedbush	Locked ➜ Locked	Locked	Aug 11 2026
Guggenheim	Locked ➜ Locked	Locked	Aug 11 2026
BTIG	Locked ➜ Locked	Locked	Aug 10 2026
Guggenheim	Locked ➜ Locked	Locked	Aug 07 2026
Citizens	Locked ➜ Locked	Locked	May 26 2026
Freedom Broker	Locked ➜ Locked	Locked	May 20 2026

Analyst Rating	Date
Locked Wedbush: Locked ➜ Locked	Sep 15 2026
Locked Wedbush: Locked ➜ Locked	Aug 11 2026
Locked Guggenheim: Locked ➜ Locked	Aug 11 2026
Locked BTIG: Locked ➜ Locked	Aug 10 2026
Locked Guggenheim: Locked ➜ Locked	Aug 07 2026
Locked Citizens: Locked ➜ Locked	May 26 2026
Locked Freedom Broker: Locked ➜ Locked	May 20 2026

Discover more stocks with a high price target

NIO ADR 86.90%

Alibaba Group Holding Ltd 80.17%

Rheinmetall 70.55%

Tencent Holdings Ltd. 60.60%

Adyen 56.67%

Uber Technologies 51.26%

BYD 49.89%

Siemens Energy 43.79%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now